JAK1 and Increased total eosinophil count: Another significant finding is the JAK1 R629_S632delinsA mutation in the pseudokinase domain, which confers growth factor independence through persistent JAK-STAT activation and demonstrates responsiveness to ruxolitinib in clonal eosinophilia [38].